감시 림프절 생검 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 시술별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Sentinel Node Biopsy Market Growth & Trends:

The global sentinel node biopsy market size is anticipated to reach USD 1.1 billion by 2030, expanding at a CAGR of 7.0% from 2024 to 2030, based on a new report by Grand View Research, Inc. This growth can be attributed to the increasing investment in cancer research and the rising awareness about sentinel node biopsy and other cancer treatment options. Moreover, the increasing competition among companies operating in the industry is expected to propel the market growth.

The growing funding for developing novel cancer treatments and increasing cancer research projects is anticipated to boost market growth. Several government and nonprofit organizations are increasing funding for cancer research. For instance, in September 2024, the Breast Cancer Research Foundation (BCRF) revealed that it is investing USD 70.3 million for breast cancer research in 2024-2025. Sentinel node biopsy is widely used in breast cancer. Thus, such funding for breast cancer disease research is expected to bring innovation in the market in the coming years.

In addition, the rising approvals from regulatory authorities for sentinel node biopsy products are anticipated to boost the market growth over the forecast period. For instance, in December 2022, Magtrace and Sentimag Magnetic Localization System from Endomagnetics Ltd. Obtained approval from the U.S. Food and Drug Administration (FDA). These systems are useful for lymph node biopsies in patients with breast cancer. Such authorizations from regulatory authorities of numerous countries are anticipated to boost the demand for the sentinel node biopsy products.

Furthermore, the rising number of initiatives focusing on increasing awareness about cancer disease and available treatment options is anticipated to support the market growth. Industry players, academic institutions, government bodies, and nonprofit organizations are undertaking several initiatives to increase knowledge of cancer treatments and symptoms. For instance, in September 2023, Hologic, Inc., a manufacturer of sentinel node biopsy products, collaborated with a nonprofit organization, Know Your Lemons, to enhance the early detection of breast cancer across the globe through empowering and creative education. Such initiatives are projected to have a positive impact on the industry growth.

Sentinel Node Biopsy Market Report Highlights:

• Based on product, in 2023, the surgical instruments segment dominated the market, accounting for 50.63% of the revenue share. This dominance can be attributed to the increasing adoption of minimally invasive surgical techniques and a growing number of clinical trials focusing on sentinel node biopsy.
• Based on application, the breast surgery segment dominated the market in 2023 and accounted for the largest revenue share of 61.51%. The other segment, which includes several types of cancer, such as melanoma and gynecological cancers, is anticipated to grow fastest from 2024 to 2030.
• Based on procedure, the open surgery segment dominated the market in 2023. In contrast, the minimally invasive surgery segment is expected to grow fastest, with the highest CAGR of 8.35% over the forecast period.
• Based on end use, the hospitals & clinics segment dominated the market in 2023, accounting for a revenue share of 74.77%. In contrast, the ambulatory surgery center segment is expected to grow fastest over the forecast period.
• Based on region, North America accounted for the largest revenue share, 44.62%, in 2023. It is also expected to grow fastest due to the growing approvals for sentinel node biopsy products from the FDA and the presence of key market players in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Sentinel Node Biopsy Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising Prevalence Of Cancer
    • 3.2.1.2. Technological Advancements
    • 3.2.1.3. Increasing Awareness About Sentinel Node Biopsy And Cancer Treatment
    • 3.2.1.4. Growing Investment For Cancer Research
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost Associated With Sentinel Node Biopsy
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Expansion In Emerging Economies
    • 3.2.3.2. Increasing Number Of Clinical Trials
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Lack Of Healthcare Professionals
• 3.3. Sentinel Node Biopsy Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Sentinel Node Biopsy Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Sentinel Node Biopsy Market Movement Analysis
• 4.3. Global Sentinel Node Biopsy Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Surgical Instruments
  • 4.4.1. Surgical Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Needles
    • 4.4.2.1. Needles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Probes
    • 4.4.3.1. Probes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Imaging Agents
  • 4.5.1. Imaging Agents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Radioactive Tracers
    • 4.5.2.1. Radioactive Tracers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Fluorescent Dyes
    • 4.5.3.1. Fluorescent Dyes Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Contrast Agents
    • 4.5.4.1. Contrast Agents Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
• 4.6. Diagnostic Kits
  • 4.6.1. Diagnostic Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.2. Equipment
    • 4.6.2.1. Equipment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.3. Reagents
    • 4.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Sentinel Node Biopsy Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Sentinel Node Biopsy Market Movement Analysis
• 5.3. Global Sentinel Node Biopsy Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Breast Cancer
  • 5.4.1. Breast Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Colon Cancer
  • 5.5.1. Colon Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Esophageal Cancer
  • 5.6.1. Esophageal Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Sentinel Node Biopsy Market: Procedure Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Sentinel Node Biopsy Market Movement Analysis
• 6.3. Global Sentinel Node Biopsy Market Size & Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
• 6.4. Open Surgery
  • 6.4.1. Open Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Minimally Invasive Surgery
  • 6.5.1. Minimally Invasive Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Sentinel Node Biopsy Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Sentinel Node Biopsy Market Movement Analysis
• 7.3. Global Sentinel Node Biopsy Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals & Clinics
  • 7.4.1. Hospital & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Ambulatory Surgery Centers
  • 7.5.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Diagnostic Centers
  • 7.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Sentinel Node Biopsy Market: Regional Estimates & Trend Analysis By Product, By Surgeries, By End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 8.3. North America
  • 8.3.1. North America Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Scenario
    • 8.3.2.4. Reimbursement Scenario
    • 8.3.2.5. U.S. Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Scenario
    • 8.3.3.4. Reimbursement Scenario
    • 8.3.3.5. Canada Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Scenario
    • 8.3.4.4. Reimbursement Scenario
    • 8.3.4.5. Mexico Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Scenario
    • 8.4.2.4. Reimbursement Scenario
    • 8.4.2.5. UK Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Scenario
    • 8.4.3.4. Reimbursement Scenario
    • 8.4.3.5. Germany Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Scenario
    • 8.4.4.4. Reimbursement Scenario
    • 8.4.4.5. France Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Scenario
    • 8.4.5.4. Reimbursement Scenario
    • 8.4.5.5. Italy Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Scenario
    • 8.4.6.4. Reimbursement Scenario
    • 8.4.6.5. Spain Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Regulatory Scenario
    • 8.4.7.4. Reimbursement Scenario
    • 8.4.7.5. Denmark Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Scenario
    • 8.4.8.4. Reimbursement Scenario
    • 8.4.8.5. Sweden Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Scenario
    • 8.4.9.4. Reimbursement Scenario
    • 8.4.9.5. Norway Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Scenario
    • 8.5.2.4. Reimbursement Scenario
    • 8.5.2.5. Japan Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Scenario
    • 8.5.3.4. Reimbursement Scenario
    • 8.5.3.5. China Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Scenario
    • 8.5.4.4. Reimbursement Scenario
    • 8.5.4.5. India Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Scenario
    • 8.5.5.4. Reimbursement Scenario
    • 8.5.5.5. South Korea Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Scenario
    • 8.5.6.4. Reimbursement Scenario
    • 8.5.6.5. Australia Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Scenario
    • 8.5.7.4. Reimbursement Scenario
    • 8.5.7.5. Thailand Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Scenario
    • 8.6.2.4. Reimbursement Scenario
    • 8.6.2.5. Brazil Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Scenario
    • 8.6.3.4. Reimbursement Scenario
    • 8.6.3.5. Argentina Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Middle East & Africa
  • 8.7.1. Middle East & Africa Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Scenario
    • 8.7.2.4. Reimbursement Scenario
    • 8.7.2.5. South Africa Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Scenario
    • 8.7.3.4. Reimbursement Scenario
    • 8.7.3.5. Saudi Arabia Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Scenario
    • 8.7.4.4. Reimbursement Scenario
    • 8.7.4.5. UAE Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Scenario
    • 8.7.5.4. Reimbursement Scenario
    • 8.7.5.5. Kuwait Sentinel Node Biopsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Key Company Profiles
  • 9.2.1. Hologic, Inc.
    • 9.2.1.1. Company Overview
    • 9.2.1.2. Financial Performance
    • 9.2.1.3. Product Benchmarking
    • 9.2.1.4. Strategic Initiatives
  • 9.2.2. Devicor Medical Products, Inc.
    • 9.2.2.1. Company Overview
    • 9.2.2.2. Financial Performance
    • 9.2.2.3. Product Benchmarking
    • 9.2.2.4. Strategic Initiatives
  • 9.2.3. KUBTEC
    • 9.2.3.1. Company Overview
    • 9.2.3.2. Financial Performance
    • 9.2.3.3. Product Benchmarking
    • 9.2.3.4. Strategic Initiatives
  • 9.2.4. SurgicEye GmbH
    • 9.2.4.1. Company Overview
    • 9.2.4.2. Financial Performance
    • 9.2.4.3. Product Benchmarking
    • 9.2.4.4. Strategic Initiatives
  • 9.2.5. Varay Laborix
    • 9.2.5.1. Company Overview
    • 9.2.5.2. Financial Performance
    • 9.2.5.3. Product Benchmarking
    • 9.2.5.4. Strategic Initiatives
  • 9.2.6. LabLogic Systems Ltd (Care Wise)
    • 9.2.6.1. Company Overview
    • 9.2.6.2. Financial Performance
    • 9.2.6.3. Product Benchmarking
    • 9.2.6.4. Strategic Initiatives
  • 9.2.7. Gamma Medical Technology
    • 9.2.7.1. Company Overview
    • 9.2.7.2. Financial Performance
    • 9.2.7.3. Product Benchmarking
    • 9.2.7.4. Strategic Initiatives
  • 9.2.8. Stryker
    • 9.2.8.1. Company Overview
    • 9.2.8.2. Financial Performance
    • 9.2.8.3. Product Benchmarking
    • 9.2.8.4. Strategic Initiatives
• 9.3. Heat Map Analysis/ Company Market Position Analysis
• 9.4. Estimated Company Market Share Analysis, 2023
• 9.5. List of Other Key Market Players